Jijin Gu
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 7
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Xianyi Sha (17 shared papers)Xiaoling Fang (17 shared papers)Xinyi Jiang (11 shared papers)Hongliang Xin (10 shared papers)Yanzuo Chen (10 shared papers)Liangcen Chen (8 shared papers)Emmanuel A. Ho (5 shared papers)Xiao Wang (2 shared papers)
- Journals
- Biomaterials (8 papers)International Journal of Pharmaceutics (5 papers)Journal of Pharmaceutical Sciences (1 paper)Acta Biomaterialia (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Jijin Gu
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 94
- Biomaterials 934
- Pharmaceutical Science 241
- Biomedical Engineering 498
- Molecular Biology 772
- Molecular Medicine 49
Countries citing papers authored by Jijin Gu
This map shows the geographic impact of Jijin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jijin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jijin Gu more than expected).
Fields of papers citing papers by Jijin Gu
This network shows the impact of papers produced by Jijin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jijin Gu. The network helps show where Jijin Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jijin Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 311 | |
| 2 | 2013 | 226 | |
| 3 | 2011 | 111 | |
| 4 | 2010 | 107 | |
| 5 | 2017 | 103 | |
| 6 | 2011 | 94 | |
| 7 | 2012 | 87 | |
| 8 | 2013 | 72 | |
| 9 | 2011 | 55 | |
| 10 | 2013 | 54 | |
| 11 | 2011 | 53 | |
| 12 | 2015 | 53 | |
| 13 | 2015 | 51 | |
| 14 | 2011 | 40 | |
| 15 | 2012 | 30 | |
| 16 | 2016 | 28 | |
| 17 | 2014 | 27 | |
| 18 | 2015 | 22 | |
| 19 | 2015 | 22 | |
| 20 | 2017 | 18 |
About Jijin Gu
Jijin Gu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Genetics and Immunology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (10 papers), Advanced biosensing and bioanalysis techniques (7 papers), Nanoplatforms for cancer theranostics (6 papers), Glioma Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (3 papers), HIV Research and Treatment (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biomaterials (934 citations), Pharmaceutical Science (241 citations), Biomedical Engineering (498 citations), Molecular Biology (772 citations) and Molecular Medicine (49 citations). Jijin Gu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Xianyi Sha, Xiaoling Fang, Xinyi Jiang, Hongliang Xin, Yanzuo Chen, Liangcen Chen, Emmanuel A. Ho, Xiao Wang, Yike Xie and Ye Jiang. Their work appears in journals such as Biomaterials, International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Acta Biomaterialia and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.